Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) EPS (Weighted Average and Diluted): 2023-2024

Historic EPS (Weighted Average and Diluted) for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$5.81.

  • Artiva Biotherapeutics' EPS (Weighted Average and Diluted) rose 109.07% to $1.35 in Q4 2024 from the same period last year, while for Dec 2024 it was -$38.81, marking a year-over-year change of. This contributed to the annual value of -$5.81 for FY2024, which is 83.76% up from last year.
  • According to the latest figures from FY2024, Artiva Biotherapeutics' EPS (Weighted Average and Diluted) is -$5.81, which was up 83.76% from -$35.78 recorded in FY2023.
  • Artiva Biotherapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$5.81 during FY2024, with a 5-year trough of -$35.78 in FY2023.
  • For the 2-year period, Artiva Biotherapeutics' EPS (Weighted Average and Diluted) averaged around -$20.80, with its median value being -$20.80 (2023).
  • Data for Artiva Biotherapeutics' EPS (Weighted Average and Diluted) shows a peak YoY surged of 83.76% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Artiva Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$35.78 in 2023, then soared by 83.76% to -$5.81 in 2024.